Compile Data Set for Download or QSAR
Report error Found 428 Enz. Inhib. hit(s) with all data for entry = 819
TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292767BDBM292767(US10106501, Example DP-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292768BDBM292768(US10106501, Example DP-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292769BDBM292769(US10106501, Example DP-3)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292770BDBM292770(US10106501, Example DU)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292771BDBM292771(US10106501, Example DU1-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292772BDBM292772(US10106501, Example DU1-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292773BDBM292773(US10106501, Example DV)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292774BDBM292774(US10106501, Example DW)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292759BDBM292759(US10106501, Example D-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292761BDBM292761((2,4-dichloro-3-((3,7-dimethyl-5-(trifluoromethyl)...)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292762BDBM292762(US10106501, Example DH1-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292763BDBM292763(US10106501, Example DH1-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292764BDBM292764(US10106501, Example DJ1-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292765BDBM292765(US10106501, Example DJ1-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292766BDBM292766(US10106501, Example DJ1-3)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292783BDBM292783(US10106501, Example EE)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292784BDBM292784(US10106501, Example EF)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292785BDBM292785(US10106501, Example EG)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292786BDBM292786(US10106501, Example EG-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292787BDBM292787(US10106501, Example EG-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292788BDBM292788(US10106501, Example EH)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292790BDBM292790(US10106501, Example EI)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292775BDBM292775(US10106501, Example DX)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292776BDBM292776(US10106501, Example DY)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292777BDBM292777(US10106501, Example DZ)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292779BDBM292779(US10106501, Example EA)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292780BDBM292780(US10106501, Example EB)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292781BDBM292781(US10106501, Example EC)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292782BDBM292782(US10106501, Example ED)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292800BDBM292800(US10106501, Example EJ-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292801BDBM292801(US10106501, Example EK)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292802BDBM292802(US10106501, Example EL)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292803BDBM292803(US10106501, Example EL-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292804BDBM292804(US10106501, Example EM)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292805BDBM292805(US10106501, Example EO | US10106501, Example EN)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292805BDBM292805(US10106501, Example EO | US10106501, Example EN)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292807BDBM292807(US10106501, Example EP)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292791BDBM292791(US10106501, Example EI-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292792BDBM292792(US10106501, Example EI-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292793BDBM292793(US10106501, Example EI-3)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292794BDBM292794(US10106501, Example EI-4)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292795BDBM292795(US10106501, Example EI-6 | US10106501, Example EI-...)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292795BDBM292795(US10106501, Example EI-6 | US10106501, Example EI-...)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292798BDBM292798(US10106501, Example EI-7)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292799BDBM292799(US10106501, Example EJ-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292816BDBM292816(US10106501, Example EY)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292817BDBM292817(US10106501, Example EZ)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292818BDBM292818(US10106501, Example F)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292819BDBM292819(US10106501, Example F1-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 292820BDBM292820(US10106501, Example F1-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

Displayed 1 to 50 (of 428 total ) | Next | Last >>
Jump to: